|
Sign In to gain access to subscriptions and/or personal tools.
|
The Clinical Spectrum of Mitochondrial Disease in 75 Pediatric Patients
D. Skladal, MD
University Children's Hospital, Innsbruck
C. Sudmeier, MD
Children's Hospital Salzburg
V. Konstantopoulou, MD
University Children's Hospital, Innsbruck
S. Stöckler-Ipsiroglu, MD
University Children's Hospital, Vienna
B. Plecko-Startinig, MD
University Children's Hospital, Graz, Austria
G. Bernert, MD
University Children's Hospital, Vienna
J. Zeman, MD
University Children's Hospital, Prague, Czech Republic
W. Sperl, MD, PhD
Children's Hospital Salzburg
The clinical presentation of mitochondrial disorders in childhood is highly variable causing difficulties in diagnosis and management. We assessed records of 75 children (48 male, 27 female) with a biochemically and/or molecularly established mitochondrial disorder in a retrospective, multicentric study. The predominant biochemical defect was an isolated respiratory chain complex IV, followed by respiratory chain complex I, combined respiratory chain, and isolated pyruvate dehydrogenase complex (PDHC) deficiencies. For the 75 patients, the predominant clinical presentations were a nonspecific encephalomyopathy (n = 34) and Leigh syndrome (n = 17). Classical mitochondrial syndromes with associated mutations of the mitochondrial DNA were rare (n = 12). Eleven children had a lethal infantile mitochondrial disease (LIMD). This group comprised a considerable variety of clinical pictures, and the cohort was big enough to show the high frequency and wide spectrum of nonneuromuscular symptoms in mitochondrial disorders in childhood.
Clinical Pediatrics, Vol. 42, No. 8,
703-710 (2003)
DOI: 10.1177/000992280304200806

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M A Gronlund, A K S. Honarvar, S Andersson, A R Moslemi, A Oldfors, E Holme, M Tulinius, and N Darin
Ophthalmological findings in children and young adults with genetically verified mitochondrial disease
Br J Ophthalmol,
January 1, 2010;
94(1):
121 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gibson, J. L. Halliday, D. M. Kirby, J. Yaplito-Lee, D. R. Thorburn, and A. Boneh
Mitochondrial Oxidative Phosphorylation Disorders Presenting in Neonates: Clinical Manifestations and Enzymatic and Molecular Diagnoses
Pediatrics,
November 1, 2008;
122(5):
1003 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-G. Debray, M. Lambert, I. Chevalier, Y. Robitaille, J.-C. Decarie, E. A. Shoubridge, B. H. Robinson, and G. A. Mitchell
Long-term Outcome and Clinical Spectrum of 73 Pediatric Patients With Mitochondrial Diseases
Pediatrics,
April 1, 2007;
119(4):
722 - 733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garcia-Cazorla, P. De Lonlay, M.C. Nassogne, P. Rustin, G. Touati, and J.M. Saudubray
Long-term Follow-up of Neonatal Mitochondrial Cytopathies: A Study of 57 Patients
Pediatrics,
November 1, 2005;
116(5):
1170 - 1177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Scaglia, J. A. Towbin, W. J. Craigen, J. W. Belmont, E. O. Smith, S. R. Neish, S. M. Ware, J. V. Hunter, S. D. Fernbach, G. D. Vladutiu, et al.
Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease
Pediatrics,
October 1, 2004;
114(4):
925 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|